Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.

Tydén, Helena; Lood, Christian; Gullstrand, Birgitta; Nielsen, Christoffer Tandrup; Heegaard, Niels H H; Kahn, Robin; Jönsen, Andreas; Bengtsson, Anders A

Tydén, Helena; Lood, Christian; Gullstrand, Birgitta; Nielsen, Christoffer Tandrup; Heegaard, Niels H H; Kahn, Robin; Jönsen, Andreas; Bengtsson, Anders A.

Afiliação

Tydén H; Department of Rheumatology, Clinical Sciences Lund, Lunds University, Lund, Sweden.
Lood C; Department of Rheumatology, Clinical Sciences Lund, Lunds University, Lund, Sweden.
Gullstrand B; Department of Rheumatology, Clinical Sciences Lund, Lunds University, Lund, Sweden.
Nielsen CT; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark.
Heegaard NHH; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kahn R; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark.
Jönsen A; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
Bengtsson AA; Department of Pediatrics, Clinical Sciences Lund, Lunds Universitey, Lund, Sweden.

RMD Open ; 3(2): e000508, 2017.

Article em En | MEDLINE | ID: mdl-29119007

Palavras-chave

cardiovascular disease; disease activity; inflammation; systemic lupus erythematosus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: RMD Open Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google